Targeted Metabolomics

Our standardized, fully automated NMR based AXINON® platform allows high-quality metabolomics for study endpoints.

We offer targeted metabolomics for companion diagnostic (CDx) development - hepatic/cardiac/renal profiles combined into constellations of relevant metabolites.

Learn more

Magnetic Group Signaling (MGS®) Technology

Magnetic Group Signaling (MGS®) standardizes NMR systems and sample processing to ensure reproducible results on different NMR instruments.

Learn More

One Sample -

All Answers

Advanced. Automated. Affordable. Mastering Metabolite Constellations for Real-Time Precision Medicine.

Learn more

AXINON® System

AXINON® is the first modular software-based system providing hardware, operating system, MGS® processor and individual test applications.

Learn more

Targeted Metabolomics. |For Companion Diagnostic Development. 

NMR based metabolomics is QUANTITATIVE and highly reproducible. numares has developed the fully-automated AXINON® platform allowing for high-quality metabolomics data to be obtained in a robust and reproducible way. 

numares offers targeted metabolomics for clinical studies - hepatic/cardiac/renal profiles combined into constellations of relevant metabolites.

 

Learn more

<i>AXINON<sup>&reg;</sup> System</i>. |Precision Diagnostics. 

AXINON® is the first modular software-based system for clinical diagnostics - providing hardware, operating system, MGS® processor and individual test applications, collectively enabling:
  •          Innovative real-time use of metabolic data
  •          Precise results for specific medical questions and diagnostic decisions
  •          Standardized analysis
  •          Multi-testing flexibility
  •          High throughput capability
  •         Fully automated lab solution
  •         High reproducibility (inter-laboratory precision)
  •         Conncectivity to lab systems (LIS/LIMS)
  •         Easy-to-use

Precision Diagnostics. |With <i>AXINON<sup>&reg;</sup></i>

Press Releases

numares’ novel multi-marker kidney function testing shows promising results…

Numares identifies new urinary biomarkers which could detect aggressive…

Numares announces Winton Gibbons as new president of US subsidiary

Social Media

The 5th edition of our customer journal is now available.

Our latest tutorial: AXINON System - Sample preparation

CLINICAL STUDY UPDATE: Close monitoring of kidney transplant patients to…

You did not activate the necessary cookies for this content.

activate necessary cookies and show content